Northwestern Mutual Wealth Management CO Cyclerion Therapeutics, Inc. Transaction History

Northwestern Mutual Wealth Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.43 - $0.9 $301 - $630	700 Added 2592.59%	727 $0
Q2 2022 Aug 04, 2022	SELL	$0.47 - $1.29 $47 - $129	-100 Reduced 78.74%	27 $0
Q2 2019 Aug 12, 2019	BUY	$9.6 - $22.85 $1,219 - $2,901	127 New	127 $1,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.